This week's Fierce Biotech is brought to you by Almac Group.

Trouble viewing? Click here.

Almac Logo

Successful trials begin with insight gained from latest IRT report

Hello there,

Major disruptors are affecting the efficiency and progress of today's clinical trials. So in May of this year, Almac Clinical Technologies set out to understand and assess these disruptors by conducting industry research with sponsor organisations of varying sizes.

Get the industry report 

See what clinical development professionals had to say about today's challenges, how this has resulted in the demand for significant changes in IRT systems, and what's now needed for a successful trial.

This complimentary report will provide vital information on:

  • Current trends in the R&D environment
  • Expectations for IRT systems within this new environment
  • The top 3 priorities to keep in mind when selecting an IRT vendor in 2020 and beyond

Happy Reading!

Almac Clinical Technologies

arc-1
Twitter Logo Linked In Logo Vimeo Logo PNG for New Guidelines.png

Please view our Privacy Policy which explains how and why we may use your personal information and the steps we take to protect it. 

If you no longer wish to receive communications from Almac Group, please opt out here.


Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact [email protected] or call 202-824-5074.



You are currently subscribed as [email protected].
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017